Pharma Focus Europe
ThermoFisher Scientific - Go beyond the catalog

Amgen Invests US$1 billion to Open New Manufacturing Site in US

Introduction:

Amgen with an investment of US$1 billion plans to open new manufacturing site. It will be the second manufacturing plant located in US.

Features:

The new manufacturing facility is designed with most advanced technologies to support the production of medicines.

Together with previously announced plans to build a new packaging plant, the company invests an additional US$1billion in manufacturing capacity to boost the increasing growth of medicines.

The new plantallows flexibility for multiple pipeline products in one plant focusing on both traditional stainless steel-fed batch manufacturing and next-generation single-use technologies.

The construction of the new plant is expected to begin in December 2021, and complete by late 2024.

The new facility is expected to generate a total of 355 full-time jobs including technicians, engineers, quality, management and administrative roles by the end of 2029.

Specifications:

NameAmgen
TypeNew manufacturing Facility
BudgetUS$1 Billion
Year2024
Latest Issue
Get instant
access to our latest e-book
Pall+CytivaAdvertisement
Lab Indonesia 2024Sartorius Lab Balance CleaningWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Advanced Therapies 2024Equinix accelerated medical research...World Vaccine Congress Washington 2024EUROPEAN PHARMA OUTSOURCING SUMMIT 2024Pharma 2024